XPH vs. THNR ETF Comparison
Comparison of SPDR S&P Pharmaceuticals ETF (XPH) to Amplify Weight Loss Drug & Treatment ETF (THNR)
XPH
SPDR S&P Pharmaceuticals ETF
XPH Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Grade (RS Rating)
Last Trade
$40.03
Average Daily Volume
25,902
40
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$26.31
Average Daily Volume
10,215
7
Performance
| Period | XPH | THNR |
|---|---|---|
| 30 Days | -0.09% | 3.88% |
| 60 Days | 1.68% | |
| 90 Days | -6.50% | |
| 12 Months | 0.05% |
XPH Overweight 36 Positions Relative to THNR
| Symbol | Grade | Weight | |
|---|---|---|---|
| ITCI | B | 5.49% | |
| OGN | B | 5.41% | |
| ELAN | B | 5.41% | |
| AXSM | B | 5.04% | |
| JAZZ | F | 4.7% | |
| ZTS | C | 4.57% | |
| JNJ | F | 4.48% | |
| CORT | B | 4.24% | |
| RPRX | D | 4.24% | |
| PRGO | F | 4.08% | |
| VTRS | D | 4.02% | |
| BMY | D | 3.72% | |
| AMPH | D | 2.1% | |
| ARVN | F | 1.94% | |
| SAVA | F | 1.88% | |
| TARS | D | 1.44% | |
| PBH | C | 1.35% | |
| PCRX | D | 1.33% | |
| LBPH | B | 1.17% | |
| HRMY | C | 1.16% | |
| INVA | B | 1.15% | |
| EYPT | F | 1.02% | |
| COLL | D | 1.01% | |
| LQDA | D | 0.99% | |
| AMRX | C | 0.98% | |
| LGND | C | 0.92% | |
| SUPN | F | 0.8% | |
| ANIP | C | 0.6% | |
| PLRX | F | 0.52% | |
| RVNC | F | 0.47% | |
| XERS | C | 0.44% | |
| EOLS | F | 0.43% | |
| OCUL | C | 0.41% | |
| TBPH | F | 0.36% | |
| FULC | F | 0.25% | |
| MRNS | D | 0.06% |
XPH: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords
Compare ETFs
